Immatics (IMTX) Common Equity (2019 - 2025)
Immatics (IMTX) reported Common Equity of $563.5 million for Q4 2025, down 8.26% on a YoY basis from $614.3 million in Q4 2024, and up 15.68% sequentially from $487.1 million in Q3 2025.
Immatics (IMTX) Common Equity (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Common Equity data on file, last reported at $563.5 million in Q4 2025.
- For the quarter ending Q4 2025, Common Equity fell 8.26% year-over-year to $563.5 million; the trailing twelve-month figure through Dec 2025 stood at $563.5 million (down 8.26% YoY), and the FY2025 full-year result was $546.9 million, down 12.09% from the prior year.
- Common Equity rose to $563.5 million in Q4 2025, from $487.1 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $614.3 million in Q4 2024 to a low of $27.5 million in Q4 2021.
- A 5-year average of $288.9 million and a median of $235.9 million in 2023 frame the typical range for Common Equity.
- Across the five-year window, Common Equity tumbled 73.58% in 2021 and surged 653.69% in 2022, its largest moves.
- Tracing IMTX's Common Equity over 5 years: stood at $27.5 million in 2021, then surged by 653.69% to $207.5 million in 2022, then gained by 12.86% to $234.1 million in 2023, then soared by 162.35% to $614.3 million in 2024, then retreated by 8.26% to $563.5 million in 2025.
- Business Quant data shows IMTX's Common Equity at $563.5 million in Q4 2025, $487.1 million in Q3 2025, and $525.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | 563.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 563.51 Mn |
| Sep 30, 2025 | 487.12 Mn |
| Jun 30, 2025 | 525.88 Mn |
| Mar 31, 2025 | 564.45 Mn |
| Dec 31, 2024 | 614.27 Mn |
| Sep 30, 2024 | 416.41 Mn |
| Jun 30, 2024 | 410.58 Mn |
| Mar 31, 2024 | 428.17 Mn |
| Dec 31, 2023 | 234.14 Mn |
| Sep 30, 2023 | 269.70 Mn |
| Jun 30, 2023 | 237.62 Mn |
| Mar 31, 2023 | 214.76 Mn |
| Dec 31, 2022 | 207.47 Mn |
| Sep 30, 2022 | 113.98 Mn |
| Jun 30, 2022 | 133.32 Mn |
| Mar 31, 2022 | 130.18 Mn |
| Dec 31, 2021 | 27.53 Mn |
| Sep 30, 2021 | 41.46 Mn |
| Jun 30, 2021 | 67.00 Mn |
| Mar 31, 2021 | 91.20 Mn |